Progression of Metastatic Pancreatic Cancer

5 意见
administrator
administrator
07/30/23

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个